The awards recognise:
- Biopharma & biotech end-users driving process development, manufacturing and commercialisation.
- CDMOs, CMOs, CROs & solution providers enabling scale, quality, and speed
- Collaborative partnerships shaping the future of biomanufacturing in Europe
The awards will be presented in conjunction with leading European bioprocessing and biopharma conferences, bringing together senior decision-makers across R&D, manufacturing, MSAT, quality, and supply chain.
Why Nominate?
- Gain industry-wide recognition from peers and partners
- Showcase technical excellence, innovation, and impact
- Strengthen brand credibility across the European biopharma ecosystem
- Celebrate teams, leaders, and partnerships behind real progress
Shortlisted organisations and individuals will be featured across official award communications and onsite at the awards ceremony.
How the Awards Work
- Open Call for Nominations: Nominations are invited from the biopharma community, including self-nominations and third-party submissions.
- Shortlisting Based on the number and quality of nominations, the Top 5–7 nominees in each category will be shortlisted.
- Final Selection Award winners will be determined through industry voting or a hybrid jury and voting process.
- Awards Ceremony Winners will be announced live at the Europe Bioprocessing Excellence Awards 2026 ceremony.
Eligibility Criteria
- Open to organisations and individuals involved in biopharmaceutical development, manufacturing, formulation, ADCs, or outsourcing
- Nominees must have operations, clients, or demonstrated impact in Europe or atleast have solutions/ technology/ pipeline that can be implemented for the Europe market.
What Judges Look For
All nominations are evaluated based on:
- Innovation & Technical Excellence
- Measurable Impact & Outcomes
- Quality of Execution
- Industry Relevance
- Clear Differentiation
Supporting evidence is strongly encouraged.
Award Categories
